The “5-SENSE” score can predict who will not benefit from stereo-electroencephalography

A new study from The Neuro (Montreal Neurological Institute-Hospital) and eight collaborating international epilepsy centers has developed a simple web-based application clinicians can use to predict which patients will not benefit from an invasive diagnostic work-up, preventing unnecessary, invasive procedures, saving time for patients and the clinical team, and freeing up overburdened health resources.

Classified as: Neuro, Birgit Frauscher, epilepsy, MNI
Published on: 6 Dec 2021

Cortical stimulation-induced seizures have the potential to guide epilepsy surgery, significantly reducing hospital stays

Surgery is the only way to stop seizures in 30 per cent of patients with focal drug-resistant epilepsy. A new study finds that inducing seizures before surgery may be a convenient and cost-effective way to determine the brain region where seizures are coming from.

Classified as: epilepsy, Birgit Frauscher, Francois Dubeau, Jean Gotman, Jeffrey Hall, Cortical stimulation
Published on: 11 Jun 2019

The institute that developed the “Montreal Procedure” continues to be on the cutting edge

The Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the “Montreal Procedure,” which today is in use throughout the world. The Neuro became a pioneer in studying epilepsy through the use of electroencephalography (EEG) and magnetic resonance imaging (MRI).

Classified as: Andrea Bernasconi, Eva Andermann, Francois Dubeau, Birgit Frauscher, Eliane Kobayashi, Jeffrey Hall, Dr Olivier, Massimo Avoli, Neda Ladbon-Bernasconi, Boris Bernhardt, Jean Gotman
Published on: 26 Mar 2018
Back to top